Vaxxas has appointed former Merck Global Vaccines president David Peacock as chief executive officer (CEO), marking a step in ...

Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.

Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...

Well, a global provider of genomic library and multiplexing workflow solutions, today announced the launch of AgriPreptm Library Prep Kit, the newest addition to its next-generation TnXtm transposase ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Are you using pimple patches correctly? Dermatologists reveal common mistakes that prevent them from working, including when ...

Biotechnology instruments market size was valued at USD 92.12 billion in 2025 and is projected to hit the market valuation of USD 141.70 billion by 2035 at a CAGR of 4.4% during the forecast period ...